Literature DB >> 8016096

Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides.

J R Perez1, Y Li, C A Stein, S Majumder, A van Oorschot, R Narayanan.   

Abstract

Modified analogues of antisense oligodeoxynucleotides (ODNs), particularly phosphorothioates ([S]ODNs), have been extensively used to inhibit gene expression. The potential sequence specificity of antisense oligomers makes them attractive as molecular drugs for human diseases. The use of antisense [S]ODNs to inhibit gene expression has been complicated by frequent nonspecific effects. In this study we show in diverse cell types that [S]ODNs, independent of their base sequence, mediated the induction of an Sp1 nuclear transcription factor. The [S]ODN-mediated Sp1 induction was rapid and was associated with elevated levels of Sp1 protein. This induction was dependent on NF-kappa B activity, since inhibition of NF-kappa B activity abolished the [S]ODN-induced Sp1 activity. [S]ODN-induced Sp1 activity was seen in mouse spleen cells following in vivo administration. Sp1 activity induced by [S]ODNs required the tyrosine kinase pathway and did not have transactivating potential. These results may help to explain some of the non-specific effects often seen with [S]ODNs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8016096      PMCID: PMC44116          DOI: 10.1073/pnas.91.13.5957

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model.

Authors:  R Narayanan; K A Higgins; J R Perez; T A Coleman; C A Rosen
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

2.  Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells.

Authors:  C A Stein; J L Tonkinson; L M Zhang; L Yakubov; J Gervasoni; R Taub; S A Rotenberg
Journal:  Biochemistry       Date:  1993-05-11       Impact factor: 3.162

3.  Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.

Authors:  C Wahlestedt; E Golanov; S Yamamoto; F Yee; H Ericson; H Yoo; C E Inturrisi; D J Reis
Journal:  Nature       Date:  1993-05-20       Impact factor: 49.962

4.  Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts.

Authors:  R Narayanan; K G Lawlor; R Q Schaapveld; K R Cho; B Vogelstein; P Bui-Vinh Tran; M P Osborne; N T Telang
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

5.  Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes.

Authors:  J A Sokoloski; A C Sartorelli; C A Rosen; R Narayanan
Journal:  Blood       Date:  1993-07-15       Impact factor: 22.113

Review 6.  Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

Authors:  C A Stein; Y C Cheng
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

7.  In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.

Authors:  M Z Ratajczak; J A Kant; S M Luger; N Hijiya; J Zhang; G Zon; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B.

Authors:  I Kitajima; T Shinohara; J Bilakovics; D A Brown; X Xu; M Nerenberg
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

9.  Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1.

Authors:  R F Branda; A L Moore; L Mathews; J J McCormack; G Zon
Journal:  Biochem Pharmacol       Date:  1993-05-25       Impact factor: 5.858

10.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.

Authors:  R Schreck; B Meier; D N Männel; W Dröge; P A Baeuerle
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Current aspects of gene therapy: implications for vascular interventions.

Authors:  F Reifers; J Kreuzer
Journal:  J Mol Med (Berl)       Date:  1995-12       Impact factor: 4.599

2.  Bioavailability of antisense oligonucleotides in neuroblastoma cells: comparison of efficacy among different types of molecules.

Authors:  M V Corrias; F Guarnaccia; M Ponzoni
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

3.  Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) 'antisense' oligodeoxynucleotide.

Authors:  L Benimetskaya; M Berton; A Kolbanovsky; S Benimetsky; C A Stein
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

4.  Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide.

Authors:  V Prasad; S Hashim; A Mukhopadhyay; S K Basu; R P Roy
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  Uptake, cellular distribution and novel cellular binding proteins of immunostimulatory CpG oligodeoxynucleotides in glioblastoma cells.

Authors:  Zhiren Zhang; Toni Weinschenk; Hermann J Schluesener
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

6.  Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1.

Authors:  S Sif; T D Gilmore
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Regulation of adhesion and growth of fibrosarcoma cells by NF-kappa B RelA involves transforming growth factor beta.

Authors:  J R Perez; K A Higgins-Sochaski; J Y Maltese; R Narayanan
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

8.  Inhibition of HSV-1 proliferation by decoy phosphodiester oligonucleotides containing ICP4 recognition sequences.

Authors:  C Clusel; S Meguenni; I Elias; M Vasseur; M Blumenfeld
Journal:  Gene Expr       Date:  1995

9.  Targeted delivery of complexes of biotin-PEG-polyethylenimine and NF-kappaB decoys to brain-derived endothelial cells in vitro.

Authors:  Raktima Bhattacharya; Berit Osburg; Dagmar Fischer; Ulrich Bickel
Journal:  Pharm Res       Date:  2007-10-20       Impact factor: 4.200

10.  Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin.

Authors:  G Hartmann; A Krug; K Waller-Fontaine; S Endres
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.